Pharma Official Says Having Employee Buy-In Key to Improving Quality
This article was originally published in The Gold Sheet
Pharma industry officials say that having strong employee buy-in is a key ingredient to improve manufacturing quality and decrease variability. An official from Eli Lilly offers a case study on how this approach helped them improve the bottom line.
You may also be interested in...
While COVID-19 continues to wreak havoc on FDA's ability to perform onsite preapproval inspections, new guidance offers some clarity, but the news isn't great for ANDA holders.
The WHO proposes to revise 2011 guidance on technology transfers to ease the hand-off of COVID-19 drugs and vaccines from research and development facilities to commercial sites.
Two groups have issued largely complementary testing methods for measuring nitrosamine impurities in drugs, and the differences that do exist are “insignificant,” EDQM official advises. The two are working to further harmonize testing standards, given the global scope of the nitrosamine scare.